Type 2 Diabetes

Physical Activity and Type 2 Diabetes: When and How Much?

Both the timing and amount of physical activity are important in risk reduction and management of type 2 diabetes.

SUSTAIN-6: Cardiovascular Safety of Semaglutide in Type 2 Diabetes

Researchers found the cardiovascular safety of semaglutide was noninferior to placebo in high-risk patients with type 2 diabetes.

How Do We Use Technology for Diabetes Management?

Edward C. Chao, DO, highlights important considerations for developing technology for diabetes management.

Implementing Diabetes Self-Management Education in Type 2 Diabetes

Joan K. Bardsley, MBA, RN, CDE, describes a joint position statement regarding implementation of diabetes self-management education.

Role of the Gut Microbiome in Diabetes

Research shows that further understanding of the gut microbiome may improve diagnosis, prevention, and treatment of the disease earlier in life.

Preventing Diabetes and Complications: What Are the Challenges?

A change in how patients and physicians view diabetes may is necessary for preventing the disease and its complications.

LEADER: Liraglutide Decreased Rate of CV Events in High-Risk Type 2 Diabetes

Compared with placebo, liraglutide decreased the rate of cardiovascular events in high-risk patients with diabetes.

SGLT2 Inhibitors: A Class Effect?

Data on cardiovascular benefits as well as adverse effects have thrust this class of diabetes drugs into the spotlight.

Physical Activity Deficiency: A New Risk Factor for Type 2 Diabetes?

Sedentary behaviors may boost risk for type 2 diabetes by 22% and risk for metabolic syndrome by 39%.

AACE Issues Consensus Statement on Outpatient Glucose Monitoring in Diabetes

The new consensus statement reflects the advances made in glucose monitoring technology and offers guidance for clinicians.

AACE/ACE Updates Algorithm for Type 2 Diabetes Management

The American Association of Clinical Endocrinologists' updated algorithm for type 2 diabetes management addresses lifestyle modifications and obesity treatments.

Video

Latest Headlines

Low Vitamin B12 Levels Associated With Long-Term Metformin Use

Low Vitamin B12 Levels Associated With Long-Term Metformin Use

Researchers found that those at risk for low vitamin B12 levels are often not properly monitored.

Insulin Resistance Impacted by Circulating Extracellular RNAs

Insulin Resistance Impacted by Circulating Extracellular RNAs

Eighteen extracellular RNAs were linked to insulin resistance across age-, sex-, and BMI-adjusted models.

Metabolic Response in Animal vs Plant Protein-Based Diets

Metabolic Response in Animal vs Plant Protein-Based Diets

While the metabolic responses to each diet were different, both diets improved patient's cardiovascular disease risk factors.

Dulaglutide Approved for Use in Combination With Basal Insulin

Dulaglutide Approved for Use in Combination With Basal Insulin

The labeling for Trulicity (dulaglutide; Eli Lilly) has been updated to include use in combination with basal insulin for adults with type 2 diabetes, following approval from the Food and Drug Administration (FDA).

Snus Consumption Identified as Risk Factor for Type 2 Diabetes

Snus Consumption Identified as Risk Factor for Type 2 Diabetes

Data was pooled for 5 cohorts to study the association between smokeless tobacco use and risk of type 2 diabetes development.

Does Air Pollution Exposure Up Type 2 Diabetes Risk?

Does Air Pollution Exposure Up Type 2 Diabetes Risk?

The presence of nitrogen dioxide and particulate matter were both linked to an increased risk of type 2 diabetes in Los Angeles-area Hispanic children.

Novel Oral GLDs Associated With Lower CVD, Mortality Risk vs Insulin

Novel Oral GLDs Associated With Lower CVD, Mortality Risk vs Insulin

Novel oral oral glucose lowering drugs were associated with lower risk of all-cause mortality and cardiovascular disease compared with insulin.

New Or Rapidly Deteriorating Type 2 Diabetes May Be Indicative of Pancreatic Cancer

New Or Rapidly Deteriorating Type 2 Diabetes May Be Indicative of Pancreatic Cancer

Newly developing or rapidly worsening type 2 diabetes may be a signal of early pancreatic cancer, according to research presented at ECCO 2017.

Injection-Free GLP-1 Receptor Agonist for T2D Under FDA Review

Injection-Free GLP-1 Receptor Agonist for T2D Under FDA Review

The Food and Drug Administration has accepted a New Drug Application for ITCA 650 (Intarcia Therapeutics) for further review in patients with type 2 diabetes.

HbA1c May Underestimate Glycemic Control in Blacks With Sickle Cell Trait

HbA1c May Underestimate Glycemic Control in Blacks With Sickle Cell Trait

The relationship between sickle cell train and hemoglobin A1c for given levels of fasting or 2-hour glucose levels among African Americans was evaluated in a retrospective cohort study.

Sign Up for Free e-Newsletters